cas 1115338-24-3|| where to buy 2-(azepan-1-yl)-3-[(4-chlorophenyl)methanesulfonyl]quinoxaline

Nom du produit:2-(azepan-1-yl)-3-[(4-chlorophenyl)methanesulfonyl]quinoxaline

IUPAC Name:2-(azepan-1-yl)-3-[(4-chlorophenyl)methanesulfonyl]quinoxaline

: CAS：1115338-24-3; Formule moléculaire：C21H22ClN3O2S; Pureté：95%+

Unité d'emballage	Stock disponible	Prix($)	Quantité

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1115338-24-3 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:1115338-24-3; Formule moléculaire:C21H22ClN3O2S; Point de fusion:-; Code SMILES:ClC1=CC=C(CS(=O)(=O)C2=C(N=C3C=CC=CC3=N2)N2CCCCCC2)C=C1; Densité:

: Numéro de catalogue:CM821085; Poids moléculaire:415.94; Point d'ébullition:; N° Mdl:; Stockage:

: Quinoxalines; Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.

: Azepanes; The use of azepane as a scaffold for drug discovery remains of interest. The azepane linker is the key to efficient activity. A number of seven-membered ring derivatives have been prepared or investigated for their potential or actual pharmacological properties. Examples include azaalkane derivatives as PKB (protein kinase B) inhibitors.